Dexamethasone: what is the breakthrough treatment for COVID-19?
UK stops recruitment to hydroxychloroquine COVID-19 trials
Another Highly-Touted Hydroxychloroquine Study Turns Out To Be A Joke
Futures Spike After Study Reveals Steroid Effective Against Advanced COVID-19
FDA warns against combination of malaria drug and Gilead’s remdesivir
The FDA backs off a hasty — and damaging — emergency OK for a potentially dangerous Covid-19 drug
U.S. FDA revokes emergency use status of drug touted by Trump for COVID-19
FDA Withdraws Emergency Authorization For Hydroxychloroquine After HHS Official Makes Request
Coronavirus pharma news roundup – 12/06/20
Researchers Uncover Which Blood Type Is Most Resistant To COVID-19... And Another Malaria Link
Big UK trial says hydroxychloroquine has no effect on COVID-19
It's easy to become an enemy of the people when speaking truth — in historic drama, and today
WHO restarts trial of COVID-19 drug hydroxychloroquine
Study panning anti-malaria drug Trump took against COVID faces new questions
HCQ Misinformation Can Be Deadly: Let Patients Decide
From the research lab to your doctor's office – here's what happens in phase 1, 2, 3 drug trials
Study shows hydroxychloroquine’s harmful effects on heart rhythm
Exclusive: Sanofi stops enrolling COVID-19 patients in hydroxychloroquine trials
Coronavirus news roundup – 29/05/2020
Hydroxychloroquine combination risky for cancer patients with COVID-19: study
France, Italy, Belgium act to stop use of hydroxychloroquine for COVID-19 on safety fears
WHO halts hydroxychloroquine trial in COVID-19 following safety concerns
Macro Briefing | 26 May 2020
Researchers define exactly what they saw in the first positive remdesivir study for Covid-19. But what's that worth to Gilead?
COVID-19 prevention trial opens for high-risk healthcare workers
Modified clinical trial protocol created in response to urgency of COVID-19 pandemic
Machine that oxygenates blood may help critically ill COVID-19 patients, according to WVU study
NIH begins clinical trial of hydroxychloroquine and azithromycin to treat COVID-19
Epic CEO Judy Faulkner on developing new therapies for COVID-19
Billionaire Bill Ackman Picks up These 2 Stocks as Markets Recover